Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

The effect of the fortifying the spleen, clearing heat, activating blood method on chronic atrophic gastritis: a real-world study

Zhihua Zheng, Yi Wen, Yanhua Yan, Zhiheng Xu, Kechao Nie, Xu Chen, Fengbin Liu, Jinglin Pan, Peiwu Li
doi: https://doi.org/10.1101/2019.12.25.19015800
Zhihua Zheng
aGuangzhou University of Chinese Medicine, Guangzhou 510000, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yi Wen
aGuangzhou University of Chinese Medicine, Guangzhou 510000, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yanhua Yan
aGuangzhou University of Chinese Medicine, Guangzhou 510000, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhiheng Xu
bDepartment of Gastroenterology, The first Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510000, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kechao Nie
aGuangzhou University of Chinese Medicine, Guangzhou 510000, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xu Chen
bDepartment of Gastroenterology, The first Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510000, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fengbin Liu
bDepartment of Gastroenterology, The first Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510000, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jinglin Pan
cDepartment of spleen-stomach and liver disease, Hainan province Hospital of Traditional Chinese Medicine, Haikou, 570100, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: doctorlipw@gzucm.edu.cn
Peiwu Li
bDepartment of Gastroenterology, The first Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510000, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: doctorlipw@gzucm.edu.cn
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Introduction Chronic atrophic gastritis (CAG) is a precancerous disease that is difficult to treat. Even after eradication of the Helicobacter pylori (HP) infection, complete resolution of the symptoms is difficult to achieve. The fortifying the spleen, clearing heat, activating blood method (FSCHABM) has an excellent curative effect in the treatment of CAG. A real-world study is particularly suitable for researching the treatment of CAG, but there are currently no reports on CAG trials. Our aim is to design a high-quality trial to investigate the efficacy and safety of FSCHABM in treating CAG patients.

Methods and analysis This protocol is designed as a real-world study for 10 years. A total of 5000 participants will be assigned to a FSCHABM treatment group or a non-FSCHABM treatment group at a 1:1 ratio at the first Affiliated Hospital of Guangzhou University of Chinese Medicine. Patients are given 1-2 courses of a 24-week-long treatment. The participants will be followed up for observation and measurement of the following indicators: the primary outcome is the histopathological indicator; the secondary outcome includes evaluation of gastric lesions, syndrome curative effect, evaluation of symptoms, evaluation of quality of life, evaluation of anxiety and depression, economic evaluation and other indicators. This is the first real-world study evaluating the therapeutic effect of FSCHABM in the treatment of CAG in clinical practice. This protocol can provide a reference for future multi-center, randomized, controlled trials.

Strengths and limitations of this study it is the first time to carry out TCM study related to CAG by using the real-world study. A large number of patients and a long-term study can effectively reflect the effect of TCM treatment and reduce the bias. The precise research protocol makes the whole research more accurate and reliable. The limitations of implementing this protocol are expending a lot of time, manpower and economic resources inevitably.

Ethics and dissemination this study was approved by Ethical committee of the first Affiliated Hospital of Guangzhou University of Chinese Medicine. Study findings will be shared with participants, healthcare providers, and policymakers through research reports, conference presentations, and the Internet. The results will also be disseminated through publication in peer reviewed journals.

Trial registration The registration number, ChiCTR1900027177, was assigned by the Chinese Clinical Trial Registry on 3 November 2019.

Funding This work was supported by Guangdong natural science fund project, China (2019),No.2019A1515011145; Major research project of Guangzhou University of Chinese medicine, China (2019), No.A1-2606-19-110-007; The first affiliated hospital of Guangzhou University of Chinese medicine “innovation foster hospital” clinical research project, China (2019), No.2019IIT19; Guangdong natural science foundation (PhD) project, China (2017), No.2017A030310121; The first affiliated hospital of Guangzhou University of Chinese medicine “innovation foster hospital” innovation research team project, China (2017), No.2017TD05; The first affiliated hospital of Guangzhou University of Chinese medicine “innovation foster hospital” Youth scientific research talent training program, China (2015), No.2015QN09.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

ChiCTR1900027177

Funding Statement

This work was supported by Guangdong natural science fund project, China (2019),No.2019A1515011145; Major research project of Guangzhou University of Chinese medicine, China (2019), No.A1-2606-19-110-007; The first affiliated hospital of Guangzhou University of Chinese medicine “innovation foster hospital” clinical research project, China (2019), No.2019IIT19; Guangdong natural science foundation (PhD) project, China (2017), No.2017A030310121; The first affiliated hospital of Guangzhou University of Chinese medicine ‘innovation foster hospital’ innovation research team project, China (2017), No.2017TD05; The first affiliated hospital of Guangzhou University of Chinese medicine ‘innovation foster hospital’ Youth scientific research talent training program, China (2015), No.2015QN09.

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Study findings will be shared with participants, healthcare providers, and policymakers through research reports, conference presentations, and the Internet. The results will also be disseminated through publication in peer reviewed journals.

  • Abbreviations

    CAG
    Chronic atrophic gastritis
    HP
    Helicobacter pylori
    FSCHABM
    the fortifying the spleen, clearing heat, activating blood method
    TCM
    traditional Chinese medicine
    RCT
    randomized controlled trial
    PRO
    patient reported outcomes
    HAD
    Hospital Anxiety and Depression Scale
    SOP
    standard operating procedures
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
    Back to top
    PreviousNext
    Posted January 13, 2020.
    Download PDF
    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    The effect of the fortifying the spleen, clearing heat, activating blood method on chronic atrophic gastritis: a real-world study
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    The effect of the fortifying the spleen, clearing heat, activating blood method on chronic atrophic gastritis: a real-world study
    Zhihua Zheng, Yi Wen, Yanhua Yan, Zhiheng Xu, Kechao Nie, Xu Chen, Fengbin Liu, Jinglin Pan, Peiwu Li
    medRxiv 2019.12.25.19015800; doi: https://doi.org/10.1101/2019.12.25.19015800
    Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
    Citation Tools
    The effect of the fortifying the spleen, clearing heat, activating blood method on chronic atrophic gastritis: a real-world study
    Zhihua Zheng, Yi Wen, Yanhua Yan, Zhiheng Xu, Kechao Nie, Xu Chen, Fengbin Liu, Jinglin Pan, Peiwu Li
    medRxiv 2019.12.25.19015800; doi: https://doi.org/10.1101/2019.12.25.19015800

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Gastroenterology
    Subject Areas
    All Articles
    • Addiction Medicine (70)
    • Allergy and Immunology (168)
    • Anesthesia (50)
    • Cardiovascular Medicine (451)
    • Dentistry and Oral Medicine (83)
    • Dermatology (55)
    • Emergency Medicine (157)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (191)
    • Epidemiology (5258)
    • Forensic Medicine (3)
    • Gastroenterology (195)
    • Genetic and Genomic Medicine (757)
    • Geriatric Medicine (80)
    • Health Economics (213)
    • Health Informatics (698)
    • Health Policy (358)
    • Health Systems and Quality Improvement (223)
    • Hematology (99)
    • HIV/AIDS (163)
    • Infectious Diseases (except HIV/AIDS) (5867)
    • Intensive Care and Critical Care Medicine (361)
    • Medical Education (104)
    • Medical Ethics (25)
    • Nephrology (83)
    • Neurology (764)
    • Nursing (43)
    • Nutrition (130)
    • Obstetrics and Gynecology (142)
    • Occupational and Environmental Health (231)
    • Oncology (479)
    • Ophthalmology (152)
    • Orthopedics (38)
    • Otolaryngology (95)
    • Pain Medicine (39)
    • Palliative Medicine (20)
    • Pathology (141)
    • Pediatrics (223)
    • Pharmacology and Therapeutics (136)
    • Primary Care Research (96)
    • Psychiatry and Clinical Psychology (862)
    • Public and Global Health (2011)
    • Radiology and Imaging (348)
    • Rehabilitation Medicine and Physical Therapy (158)
    • Respiratory Medicine (285)
    • Rheumatology (94)
    • Sexual and Reproductive Health (74)
    • Sports Medicine (76)
    • Surgery (109)
    • Toxicology (25)
    • Transplantation (29)
    • Urology (39)